• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    3/14/23 1:24:58 PM ET
    $AAP
    $ACRX
    $ADCT
    $AKTX
    Auto & Home Supply Stores
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAP alert in real time by email

     

    Tuesday's morning session saw 84 companies set new 52-week lows.

    Things to Consider About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was CVS Health (NYSE:CVS).
    • ThermoGenesis Holdings (NASDAQ:THMO) was the smallest firm by market cap to set a new 52-week low.
    • Oportun Financial (NASDAQ:OPRT) shares dropped the most, trading down 28.16% to reach its new 52-week low.
    • Sigmatron International (NASDAQ:SGMA) was the biggest winner of the bunch, with shares actually trading up 0.01% after it rebounded from its new 52-week low.

    Here is a list of stocks that set new 52-week lows on Tuesday:

    • CVS Health (NYSE:CVS) shares fell to $75.85 on Tuesday, setting a new 52-week low with a shift of up 0.14%.
    • Sirius XM Holdings (NASDAQ:SIRI) stock hit a new 52-week low of $3.61. The stock was up 0.34% on the session.
    • Centrais Eletricas (NYSE:EBR) stock hit a new 52-week low of $5.97. The stock was up 0.66% on the session.
    • Boston Props (NYSE:BXP) shares set a new yearly low of $55.25 this morning. The stock was up 0.67% on the session.
    • Advance Auto Parts (NYSE:AAP) stock achieved a new 52-week low on Tuesday morning, hitting $122.97 and moving down 0.85%.
    • KT (NYSE:KT) stock broke to a new 52-week low of $11.24 on Tuesday. Shares of the company traded down 0.22%.
    • Organon (NYSE:OGN) shares hit a yearly low of $22.15. The stock was up 0.04% on the session.
    • Amedisys (NASDAQ:AMED) shares set a new yearly low of $77.39 this morning. The stock was down 4.37% on the session.
    • Kohl's (NYSE:KSS) shares set a new 52-week low of $22.12. The stock traded down 2.06%.
    • Inter & Co (NASDAQ:INTR) shares fell to $1.67 on Tuesday, setting a new 52-week low with a shift of down 3.43%.
    • Genesco (NYSE:GCO) stock dropped to a yearly low on Tuesday of $36.60. Shares traded down 1.26%.
    • VNET Gr (NASDAQ:VNET) stock broke to a new 52-week low of $2.90 on Tuesday. Shares of the company traded up 2.81%.
    • Ioneer (NASDAQ:IONR) stock hit a yearly low of $7.88. The stock was down 5.61% for the day.
    • Benson Hill (NYSE:BHIL) shares made a new 52-week low of $1.65 on Tuesday. The stock was down 7.3% for the day.
    • Esperion Therapeutics (NASDAQ:ESPR) shares reached a new 52-week low of $4.10 on Tuesday morning, moving down 2.7%.
    • Cara Therapeutics (NASDAQ:CARA) shares hit a yearly low of $5.78. The stock was up 0.86% on the session.
    • Douglas Elliman (NYSE:DOUG) shares reached a new 52-week low of $3.18 on Tuesday morning, moving up 0.31%.
    • Torrid Holdings (NYSE:CURV) stock achieved a new 52-week low on Tuesday morning, hitting $2.39 and moving down 4.3%.
    • Grindrod Shipping Hldgs (NASDAQ:GRIN) stock hit a yearly low of $12.66. The stock was down 0.12% for the day.
    • Nektar Therapeutics (NASDAQ:NKTR) stock broke to a new 52-week low of $1.15 on Tuesday. Shares of the company traded down 1.25%.
    • Amneal Pharmaceuticals (NYSE:AMRX) shares moved down 4.08% on Tuesday to hit a new 52-week low of $1.40, drifting down 4.08%.
    • Morgan Stanley India (NYSE:IIF) stock hit a yearly low of $19.41. The stock was down 0.02% for the day.
    • ADC Therapeutics (NYSE:ADCT) shares hit a yearly low of $2.45. The stock was down 1.77% on the session.
    • ATAI Life Sciences (NASDAQ:ATAI) shares moved down 3.2% on Tuesday to hit a new 52-week low of $1.20, drifting down 3.2%.
    • Investar Holding (NASDAQ:ISTR) shares fell to $16.49 on Tuesday, setting a new 52-week low with a shift of up 0.06%.
    • 1stdibs.com (NASDAQ:DIBS) stock hit $3.96 on Tuesday morning, setting a new 52-week low for a change of down 0.86%.
    • Dragonfly Energy Hldgs (NASDAQ:DFLI) shares made a new 52-week low of $3.21 on Tuesday. The stock was down 8.03% for the day.
    • Nuveen Arizona Quality (NYSE:NAZ) stock hit a yearly low of $11.07. The stock was down 0.51% for the day.
    • Turtle Beach (NASDAQ:HEAR) stock achieved a new 52-week low on Tuesday morning, hitting $6.17 and moving down 3.06%.
    • Precision BioSciences (NASDAQ:DTIL) stock hit $0.86 on Tuesday morning, setting a new 52-week low for a change of down 2.39%.
    • Oportun Financial (NASDAQ:OPRT) stock set a new 52-week low of $2.90 on Tuesday, moving down 28.16%.
    • Movella Holdings (NASDAQ:MVLA) stock set a new 52-week low of $1.62 on Tuesday, moving down 2.37%.
    • AEye (NASDAQ:LIDR) stock drifted down 1.65% on Tuesday morning to hit a new 52-week low of $0.45.
    • Sarcos Technology (NASDAQ:STRC) stock hit a yearly low of $0.49. The stock was down 0.51% for the day.
    • Theratechnologies (NASDAQ:THTX) stock drifted up 5.4% on Tuesday morning to hit a new 52-week low of $0.70.
    • Chicken Soup for the Soul (NASDAQ:CSSE) stock hit $3.12 on Tuesday morning, setting a new 52-week low for a change of down 0.31%.
    • Aurora Mobile (NASDAQ:JG) shares set a new 52-week low of $0.56. The stock traded down 3.33%.
    • Portage Biotech (NASDAQ:PRTG) shares moved down 1.96% on Tuesday to hit a new 52-week low of $2.98, drifting down 1.96%.
    • Local Bounti (NYSE:LOCL) stock dropped to a yearly low on Tuesday of $0.42. Shares traded down 3.75%.
    • VirTra (NASDAQ:VTSI) shares moved up 1.99% on Tuesday to hit a new 52-week low of $4.00, drifting up 1.99%.
    • RF Industries (NASDAQ:RFIL) shares fell to $4.14 on Tuesday, setting a new 52-week low with a shift of down 7.89%.
    • Energous (NASDAQ:WATT) shares were down 2.33% for the day, having made a 52-week low of $0.51.
    • ReWalk Robotics (NASDAQ:RWLK) shares made a new 52-week low of $0.68 on Tuesday. The stock was down 4.11% for the day.
    • MultiMetaVerse Holdings (NASDAQ:MMV) shares were down 4.1% for the day, having made a 52-week low of $1.15.
    • P3 Health Partners (NASDAQ:PIII) shares set a new 52-week low of $0.88. The stock traded down 5.02%.
    • BM Technologies (AMEX:BMTX) shares hit a yearly low of $2.82. The stock was down 3.38% on the session.
    • Toro (NASDAQ:TORO) shares were down 13.94% for the day, having made a 52-week low of $3.30.
    • Science 37 Hldgs (NASDAQ:SNCE) stock set a new 52-week low of $0.21 on Tuesday, moving up 6.78%.
    • Atento (NYSE:ATTO) stock dropped to a yearly low on Tuesday of $1.81. Shares traded down 7.04%.
    • Nogin (NASDAQ:NOGN) shares were down 2.63% for the day, having made a 52-week low of $0.36.
    • Adamas One (NASDAQ:JEWL) stock hit a yearly low of $1.10. The stock was up 1.76% for the day.
    • Impel Pharmaceuticals (NASDAQ:IMPL) shares made a new 52-week low of $0.96 on Tuesday. The stock was down 7.48% for the day.
    • Lucy Scientific Discovery (NASDAQ:LSDI) shares reached a new 52-week low of $1.24 on Tuesday morning, moving down 7.3%.
    • Sigmatron International (NASDAQ:SGMA) shares fell to $3.34 on Tuesday, setting a new 52-week low with a shift of up 0.01%.
    • Akari Therapeutics (NASDAQ:AKTX) stock dropped to a yearly low on Tuesday of $0.27. Shares traded down 6.21%.
    • Ryvyl (NASDAQ:RVYL) stock drifted down 4.63% on Tuesday morning to hit a new 52-week low of $0.38.
    • Sonnet BioTherapeutics (NASDAQ:SONN) stock broke to a new 52-week low of $0.59 on Tuesday. Shares of the company traded down 3.73%.
    • Safe & Green Holdings (NASDAQ:SGBX) shares set a new yearly low of $0.87 this morning. The stock was up 1.28% on the session.
    • Aridis Pharmaceuticals (NASDAQ:ARDS) stock dropped to a yearly low on Tuesday of $0.35. Shares traded down 23.89%.
    • Digital Ally (NASDAQ:DGLY) stock hit $3.90 on Tuesday morning, setting a new 52-week low for a change of down 1.02%.
    • Fresh Vine Wine (AMEX:VINE) shares set a new 52-week low of $0.72. The stock traded down 1.08%.
    • Jupiter Wellness (NASDAQ:JUPW) shares made a new 52-week low of $0.31 on Tuesday. The stock was down 4.29% for the day.
    • AcelRx Pharmaceuticals (NASDAQ:ACRX) shares hit a yearly low of $0.89. The stock was down 15.95% on the session.
    • Biocept (NASDAQ:BIOC) stock hit a new 52-week low of $0.38. The stock was down 1.48% on the session.
    • NextPlay Technologies (NASDAQ:NXTP) shares were down 9.25% for the day, having made a 52-week low of $0.98.
    • Nuwellis (NASDAQ:NUWE) stock hit a new 52-week low of $4.61. The stock was down 1.78% on the session.
    • NanoVibronix (NASDAQ:NAOV) stock dropped to a yearly low on Tuesday of $2.94. Shares traded up 14.29%.
    • IMAC Holdings (NASDAQ:BACK) shares fell to $0.15 on Tuesday, setting a new 52-week low with a shift of up 5.2%.
    • ComSovereign Holding (NASDAQ:COMS) shares set a new 52-week low of $1.89. The stock traded down 5.24%.
    • Reliance Global Group (NASDAQ:RELI) shares reached a new 52-week low of $3.52 on Tuesday morning, moving down 0.27%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares fell to $0.13 on Tuesday, setting a new 52-week low with a shift of down 4.74%.
    • Windtree Therapeutics (NASDAQ:WINT) shares hit a yearly low of $4.28. The stock was down 0.68% on the session.
    • Aspen Gr (NASDAQ:ASPU) shares reached a new 52-week low of $0.11 on Tuesday morning, moving down 21.18%.
    • LogicMark (NASDAQ:LGMK) shares reached a new 52-week low of $0.13 on Tuesday morning, moving up 5.87%.
    • Petros Pharmaceuticals (NASDAQ:PTPI) stock hit a new 52-week low of $1.51. The stock was down 3.7% on the session.
    • First Wave BioPharma (NASDAQ:FWBI) stock broke to a new 52-week low of $2.76 on Tuesday. Shares of the company traded down 6.17%.
    • Mobiquity Technologies (NASDAQ:MOBQ) shares reached a new 52-week low of $0.19 on Tuesday morning, moving down 7.24%.
    • ThermoGenesis Holdings (NASDAQ:THMO) shares hit a yearly low of $2.11. The stock was up 1.35% on the session.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $AAP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAP
    $ACRX
    $ADCT
    $AKTX

    CompanyDatePrice TargetRatingAnalyst
    BXP Inc.
    $BXP
    2/24/2026$62.00Outperform → Neutral
    Mizuho
    RF Industries Ltd.
    $RFIL
    2/19/2026$10.25Buy → Neutral
    B. Riley Securities
    Nektar Therapeutics
    $NKTR
    2/10/2026Mkt Perform → Outperform
    William Blair
    SiriusXM Holdings Inc.
    $SIRI
    2/10/2026$24.00Underweight → Neutral
    Analyst
    SiriusXM Holdings Inc.
    $SIRI
    2/6/2026Buy → Neutral
    Seaport Research Partners
    SiriusXM Holdings Inc.
    $SIRI
    1/27/2026$21.00Neutral
    MoffettNathanson
    Advance Auto Parts Inc.
    $AAP
    1/21/2026$55.00Neutral → Buy
    Northcoast
    AtaiBeckley Inc.
    $ATAI
    1/20/2026$11.00Buy
    Guggenheim
    More analyst ratings

    $AAP
    $ACRX
    $ADCT
    $AKTX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brown Jeffrey Dale bought $30,724 worth of shares (6,860 units at $4.48), increasing direct ownership by 6% to 60,623 units (SEC Form 4)

    4 - VirTra, Inc (0001085243) (Issuer)

    2/17/26 9:15:11 AM ET
    $VTSI
    Miscellaneous manufacturing industries
    Consumer Discretionary

    EVP and President, Aetna Nelson Steven H bought $1,289 worth of shares (24 units at $53.70) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    1/27/26 5:20:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Dietze Jane A bought $99,485 worth of Series A Perpetual Stretch Preferred Stock (1,000 units at $99.48), increasing direct ownership by 38% to 3,600 units (SEC Form 4)

    4 - Strategy Inc (0001050446) (Issuer)

    1/21/26 4:45:05 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    $AAP
    $ACRX
    $ADCT
    $AKTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BXP, Inc. downgraded by Mizuho with a new price target

    Mizuho downgraded BXP, Inc. from Outperform to Neutral and set a new price target of $62.00

    2/24/26 7:41:54 AM ET
    $BXP
    Real Estate Investment Trusts
    Real Estate

    RF Industries downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded RF Industries from Buy to Neutral and set a new price target of $10.25

    2/19/26 7:50:44 AM ET
    $RFIL
    Electrical Products
    Technology

    Nektar Therapeutics upgraded by William Blair

    William Blair upgraded Nektar Therapeutics from Mkt Perform to Outperform

    2/10/26 11:48:14 AM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $ACRX
    $ADCT
    $AKTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments

    Issued on behalf of Helus PharmaVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Psychedelic compounds are edging closer to regulatory approval as pivotal trials in treatment-resistant depression and anxiety advance through late-stage development[1]. The sector is shedding its countercultural reputation as biotech firms reposition serotonergic and psychedelic-derived therapies as mainstream pharmaceutical candidates[2]. Five companies are building the clinical programs to get there: Helus Pharma (NASDAQ:HELP), AtaiBeckley (NASDAQ:ATAI), Definium Therapeutics (NASDAQ:DFTX), GH Research (NASDAQ:GHRS), and LB Pharmaceuticals (NASDAQ:LBRX).

    2/27/26 11:44:00 AM ET
    $ATAI
    $DFTX
    $GHRS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products

    VNET Announces US$138 Million Private Placement

    BEIJING, Feb. 27, 2026 /PRNewswire/ -- VNET Group, Inc. (Nasdaq: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced a private placement of 81.0 million newly issued Class A ordinary shares of the Company ("Placement Shares") to certain institutional investors at an offering price of US$1.7 per Placement Share (or US$10.2 per ADS, each representing six Class A ordinary shares) (the "Private Placement"). The Company expects to close the Private Placement on or about March 3, 2026, subject to customary closing conditions. Gross proceeds from the Private Placement financing are anticipated to be approximately US$

    2/27/26 9:10:00 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    New Analysis of Organon's VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis

    Clinically meaningful improvements in sleep scores, as measured by subdomains of the Patient-Oriented Eczema Measure (POEM) and Dermatitis Family Impact (DFI) assessments, were observed as early as week 1 and continued through week 8 Organon (NYSE:OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will present results from a sub-analysis of pooled data from the Phase 3 ADORING 1 and ADORING 2 pivotal trials evaluating VTAMA cream versus vehicle at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Philadelphia, Pennsylvania, on February 27, 2026. The findings show that VTAMA cream prov

    2/27/26 8:00:00 AM ET
    $OGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $ACRX
    $ADCT
    $AKTX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $ACRX
    $ADCT
    $AKTX
    SEC Filings

    View All

    IMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - IMAC Holdings, Inc. (0001729944) (Filer)

    2/27/26 4:00:35 PM ET
    $BACK
    Medical Specialities
    Health Care

    SEC Form 6-K filed by VNET Group Inc.

    6-K - VNET Group, Inc. (0001508475) (Filer)

    2/27/26 9:15:16 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    SEC Form S-8 filed by 1stdibs.com Inc.

    S-8 - 1stdibs.com, Inc. (0001600641) (Filer)

    2/27/26 8:55:32 AM ET
    $DIBS
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AAP
    $ACRX
    $ADCT
    $AKTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice President Spann Hilary J. converted options into 5,495 shares, increasing direct ownership by 31% to 23,327 units (SEC Form 4)

    4 - BXP, Inc. (0001037540) (Issuer)

    2/26/26 3:59:13 PM ET
    $BXP
    Real Estate Investment Trusts
    Real Estate

    New insider Barber Grant claimed ownership of 11,125 shares (SEC Form 3)

    3 - VirTra, Inc (0001085243) (Issuer)

    2/25/26 4:05:14 PM ET
    $VTSI
    Miscellaneous manufacturing industries
    Consumer Discretionary

    SEC Form 3 filed by new insider Castro Joseph

    3 - NUVEEN ARIZONA QUALITY MUNICIPAL INCOME FUND (0000892992) (Issuer)

    2/23/26 11:07:37 AM ET
    $NAZ
    Finance/Investors Services
    Finance

    $AAP
    $ACRX
    $ADCT
    $AKTX
    Leadership Updates

    Live Leadership Updates

    View All

    Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

    TAMPA, Fla. and LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today announced the appointment of Prafulla Gokhale, Ph.D., Director of the Experimental Therapeutics Core and the Lurie Family Imaging Center at Dana-Farber Cancer Institute, to its Scientific Advisory Board. "Dr. Gokhale's expertise in experimental therapeutics, RNA biology and translational oncology comes at a pivotal time as we advance AKTX-101 toward the clinic," commented Abizer Gaslightwala, President and CEO of Akari Therapeutics. "His proven track record to develop novel t

    2/26/26 9:10:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors

    MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of David A. McDonald and Martin J. Emerson to its Board of Directors, effective February 24, 2026. The appointments strengthen the Company's board with complementary expertise in public company leadership, capital markets, and medical device commercialization. "These appointments reflect our continued focus on operational discipline and long-term value creation," said John Erb, President and CEO of Nuwellis. "Marty has led multiple medical device organizations through scali

    2/26/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Kohl's Corporation Declares Quarterly Dividend

    The Board of Directors of Kohl's Corporation (NYSE:KSS) ("Kohl's" or the "Company") today declared a regular quarterly dividend of $0.125 per share on the Company's common stock. The dividend is payable April 1, 2026, to shareholders of record at the close of business on March 18, 2026. About Kohl's Kohl's (NYSE:KSS) is a leading omnichannel retailer built on a foundation that combines great brands, incredible value and convenience for our customers. Kohl's is uniquely positioned to deliver against its long-term strategy and its purpose to take care of families' realest moments. Kohl's serves millions of families in its more than 1,100 stores in 49 states, online at Kohls.com, and throu

    2/25/26 4:15:00 PM ET
    $KSS
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AAP
    $ACRX
    $ADCT
    $AKTX
    Financials

    Live finance-specific insights

    View All

    Amneal Reports Fourth Quarter and Full Year 2025 Financial Results

    ‒ Full Year 2025 Performance Met or Exceeded All Guidance Metrics and 2026 Reflects Another Year of Growth – ‒ Q4 2025 Net Revenue of $814 million; GAAP Net Income of $35 million; Diluted Income per Share of $0.11 ‒ ‒ Q4 2025 Adjusted Net Income of $68 million, Adjusted EBITDA of $175 million; Adjusted Diluted EPS of $0.21 ‒ ‒ Full Year 2025 Net Revenue of $3.02 billion; GAAP Net Income of $72 million; Diluted Income per Share of $0.22 ‒ ‒ Full Year 2025 Adjusted Net Income of $269 million; Adjusted EBITDA of $688 million; Adjusted Diluted EPS of $0.83 ‒ ‒ Provides 2026 Financial Guidance of $3.05 to $3.15 billion in net revenue, $720 to $760 million in Adjusted EBITDA, and $0.93 to $1.0

    2/27/26 6:00:00 AM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets

    SAN FRANCISCO, Feb. 26, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2025 on Thursday, March 12, 2026, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time. This press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar web

    2/26/26 6:00:00 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sirius XM Radio LLC Prices Upsized Offering of $1,250,000,000 of 5.875% Senior Notes Due 2032

    NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASDAQ:SIRI) ("SiriusXM") announced today that its subsidiary, Sirius XM Radio LLC, (the "Issuer") priced an offering of $1,250,000,000 of 5.875% Senior Notes due 2032 (the "Notes"). This represents an increase of $250,000,000 in aggregate principal amount in the offering size of the Notes. The sale of the Notes is expected to be consummated on or about March 4, 2026, subject to customary closing conditions. The Notes are to be sold to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, and non-U.S. persons outside the United States in compliance w

    2/26/26 5:45:00 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    $AAP
    $ACRX
    $ADCT
    $AKTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Advance Auto Parts Inc.

    SC 13G/A - ADVANCE AUTO PARTS INC (0001158449) (Subject)

    12/9/24 6:02:26 AM ET
    $AAP
    Auto & Home Supply Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Akari Therapeutics plc

    SC 13D/A - Akari Therapeutics Plc (0001541157) (Subject)

    12/6/24 4:00:28 PM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care